Codexis

Yahoo Finance • 4 months ago

Codexis Announces New Employment Inducement Grants

Codexis, Inc. REDWOOD CITY, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to three new employees as approved by the Compensatio... Full story

Yahoo Finance • last year

Is It Time To Consider Buying Codexis, Inc. (NASDAQ:CDXS)?

Codexis, Inc. (NASDAQ:CDXS), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the NASDAQGS over the last few months. As a stock with high coverage by analysts, you could assume any rec... Full story

Yahoo Finance • last year

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

Codexis, Inc.; Aldevron Deal creates strategic collaboration to enable more efficient RNA therapeutic development, providing a path to GMP-grade Codexis enzymes REDWOOD CITY, Calif. and FARGO, N.D., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Code... Full story

Yahoo Finance • last year

Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform

Codexis, Inc. Milestone enables Codexis engineers to model the manufacturing process for RNAi therapeutics Company remains on track to initiate pre-commercial customer testing in 2024 REDWOOD CITY, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE)... Full story

Yahoo Finance • last year

Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023

REDWOOD CITY, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it will host a virtual key opinion leader (KOL) event focused on its Enzyme-Catalyzed Oligonucleo... Full story

Yahoo Finance • last year

Catherine Wood Adjusts Portfolio, Trims Tesla Stake by 1.33%

ARK Investment Management's Latest 13F Filing Highlights Key Stock Movements Renowned for her focus on disruptive innovation, Catherine Wood (Trades, Portfolio), the founder and CEO of ARK Investment Management, has made notable changes t... Full story

Yahoo Finance • last year

Codexis to Participate in 35th Annual Piper Sandler Healthcare Conference

REDWOOD CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the 35th Annual Piper Sandler Healthcare Conference, being held November... Full story

Yahoo Finance • last year

Q3 2023 Codexis Inc Earnings Call

Participants Carrie McKim; IR; Codexis, Inc. Stephen Dilly; President & CEO; Codexis, Inc. Kevin Norrett; CFO; Codexis, Inc. Sri Ryali; CFO; Codexis, Inc. Brandon Couillard; Analyst; Jefferies & Co. Matthew Hewitt; Analyst; Craig-Hal... Full story

Yahoo Finance • last year

Codexis, Inc. (NASDAQ:CDXS) Q3 2023 Earnings Call Transcript

Codexis, Inc. (NASDAQ:CDXS) Q3 2023 Earnings Call Transcript November 2, 2023 Codexis, Inc. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.32. Operator: Welcome to the Codexis Third Quarter 2023 Earning... Full story

Yahoo Finance • last year

INVESTOR ALERT: Abbott Cooper PLLC Announces Investigation into Codexis, Inc.; Urges Codexis Stockholders to Contact Abbott Cooper Regarding Their Legal Rights

STAMFORD, Conn., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating Codexis, Inc. (Nasdaq: CDXS) (“Codexis” or the “Company”) on behalf of the Company’s investors. The investigation seeks to determine whether Codexis’... Full story

Yahoo Finance • last year

Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe

REDWOOD CITY, Calif., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced a presentation highlighting the role of an enzymatic approach to support RNA-based therapeutics m... Full story

Yahoo Finance • last year

Codexis to Report Third Quarter 2023 Financial Results on November 2

REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the third quarter of 2023 on Thursday, November 2,... Full story

Yahoo Finance • last year

Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award

REDWOOD CITY, Calif., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced President and Chief Executive Officer Stephen Dilly, MBBS, PhD, has been named the winner of the... Full story

Yahoo Finance • last year

Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award

REDWOOD CITY, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced Stephen Dilly, MBBS, PhD, President and Chief Executive Officer of Codexis, has been named a fin... Full story

Yahoo Finance • last year

Codexis to Participate in Cantor Global Healthcare Conference

REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Cantor Global Healthcare Conference, being held September 26-28, 202... Full story

Yahoo Finance • last year

Codexis Announces Agreement for Assignment and Assumption of San Carlos Facility Lease

REDWOOD CITY, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company has executed an Assignment and Assumption of Lease for its San Carlos, California lo... Full story

Yahoo Finance • 2 years ago

Codexis Unveils ECO Synthesis™ Platform for Large-Scale RNAi Therapeutics Production at TIDES USA

REDWOOD CITY, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the unveiling of its Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis™ technology, a proprietary n... Full story

Yahoo Finance • 2 years ago

Codexis to Report First Quarter 2023 Financial Results on May 4

REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the first quarter of 2023 on Thursday, May 4, 2023... Full story

Yahoo Finance • 2 years ago

Codexis Announces RNA Therapeutics Manufacturing Workshop at TIDES USA

REDWOOD CITY, Calif., April 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it will host a pre-conference workshop highlighting the role of an enzymatic approach to support... Full story

Yahoo Finance • 2 years ago

Codexis Announces Decision of Patrick Yang, PhD, Not to Seek Re-Election to Board of Directors

REDWOOD CITY, Calif., April 04, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that Patrick Yang, PhD, will not seek re-election to the Codexis Board of Directors. Dr. Yang jo... Full story